A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine

Clinical trial NCT01740284 · COMPLETED

Trial details

NCT number: NCT01740284
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis

Start date: 2008-09-01
Primary completion: 2009-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.